ABSTRACT
The relationship between characteristics of HIV antiretroviral regimens and treatment adherence was studied in adolescent and adult patients who underwent antiretroviral therapy from January 1998 to September 2000, at the Service for Specialized Assistance in Pelotas. The patients were interviewed on two occasions, and the use of antiretrovirals during the previous 48 hours was investigated by a self-report. Adherence was defined as use of 95 percent or more of the prescribed medication. Social-demographic variables were collected through direct questionnaires. The antiretroviral regimen and clinical data were copied from the patients' records. Associations between the independent variables and adherence were analyzed by means of logistic regression. The multivariate analysis included characteristics of the antiretroviral regimens, social-demographic variables, as well as perception of negative effects, negative physiological states, and adverse effects of the treatment. Among the 224 selected patients, 194 participated in our study. Their ages varied from 17 to 67 years; most patients were men, with few years of schooling and a low family income. Only 49 percent adhered to the treatment. Adherence to treatment regimens was reduced when more daily doses were indicated: three to four doses (odds ratio of adherence to treatment (OR)=0.47, 95 percent confidence interval (CI) 0.22-1.01) and five to six (OR=0.24, 95 percent CI 0.09-0.62); two or more doses taken in a fasting state (OR=0.59, 95 percent CI 0.11-0.68), and for patients who reported adverse effects to the treatment (OR=0.39, 95 percent CI 0.19-0.77). Most of the regimens with more than two daily doses of medication included at least one dose apart from mealtimes. The results suggest that, if possible, regimens with a reduced number of doses should be chosen, with no compulsory fasting, and with few adverse effects. Strategies to minimize these effects should be discussed with the patients
Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Anti-HIV Agents , HIV Infections , Patient Compliance , Drug Administration Schedule , Interviews as Topic , Middle Aged , Multivariate Analysis , Odds Ratio , Socioeconomic FactorsABSTRACT
Factors associated with undetectable viral load (<80 copies/ml) were investigated among non-pregnant adults in antiretroviral treatment in a specialized service for HIV/AIDS in Southern Brazil. Use of antiretrovirals was investigated in two interviews (one month interval). Clinical data were collected from the clinical records; viral load previous to adherence measurement was defined the viral load previous to the first interview; the final viral load, the viral load subsequent to the second interview (interval between measures approximately 6 months). Undetectable final viral load occurred in 48 of the patients and was positively associated with levels of treatment adherence (p<0.001), being 19 for less than 60 of adherence and about 60 for adherence greater than 80. In the multivariate model, the odds of undetectable final viral load was four times greater for 80-94 and > or =95 of adherence (CI 95 1,80-13,28; CI 95 1,73-9,53), compared with less than 60 adherence; it was greater for less than 6 months in treatment (OR = 3.37; CI 95 1.09-10.46); and smaller for viral load previous to adherence measurement 5.2 log10 (OR = 0.19; CI95 0.06-0.58), adjusted for these variables and sex, age, clinical status, current immune status, group of drugs and interval between the two measurements of viral load. The crude odds were lower for age 16-24 years and use of Nucleoside Analog Reverse Transcriptase Inhibitors only, but these effects were not significant in the multivariate model. There was no evidence of effect of sex, clinical status, current immune status, and changes in treatment regimen. Treatment adherence gave the largest effect. Motivational interventions directed at adherence may improve treatment effectiveness.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Anti-HIV Agents , HIV , HIV Infections/drug therapy , HIV Infections/virology , Viral Load , Brazil , Drug Therapy, Combination , HIV , HIV Protease Inhibitors , HIV Infections/classification , HIV Infections/immunology , Patient Compliance , Odds Ratio , Reverse Transcriptase Inhibitors , Risk Factors , Socioeconomic FactorsABSTRACT
Uma escala de expectativa de auto-eficácia para seguir prescriçäo anti-retroviral em situaçöes difíceis (21 itens) foi desenvolvida pela análise do conteúdo de entrevistas com pacientes que estavam em tratamento ou que o abandonaram. A consistência interna e a validade de construto foram examinadas em 60 sujeitos que freqüentaram ambulatório para pacientes em estágios avançados da doença (hospital-dia). Um escore de expectativa de auto-eficácia para adesäo ao tratamento foi derivado do primeiro componente da análise de componentes principais. A média do escore foi 0,25 para os sujeitos aderentes e -0,33 para os näo-aderentes ao tratamento (teste t, p = 0,046). A chance de adesäo duplicou quando o escore de expectativa de auto-eficácia era maior em uma unidade (OR = 2,07; IC95 por cento = 1,002 a 4,26). A consistência interna foi alta (alfa de Cronbach = 0.96). A escala demonstrou validade de construto e confiabilidade para medir auto-eficácia para tratamento anti-retroviral nesses pacientes